The primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood glucose levels without causing hypoglycaemia when used alone Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake GLP-1 receptor agonists are typically administered via subcutaneous injection, with dosing frequencies ranging from once daily to once weekly depending on the specific medication, though oral semaglutide (Rybelsus) is also available
not independently peer-reviewed by Astral
Electrolyte + Ginger Tracker Stay on top of your hydration and routine with visual checkboxes
Resveratrol (Grape Skin Extract, 98% purity) Extends GLP-1 activity for lasting appetite regulation, antioxidant metabolic support
[13] [14] [15] [16] [17] Adverse events are most commonly gastrointestinal symptoms such as nausea and diarrhea, with relatively low rates of study discontinuation and infrequent serious adverse events reported during trials
Supplementary figure S2B shows the propensity score distribution of the GLP-1 receptor agonist and SGLT-2 inhibitor cohorts before and after weighting